OpenURL Connection Search

Select item for more details and to access through your institution.

A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer.
Published in:
2010
By:
- Pillaire, M-J;
- Selves, J;
- Gordien, K;
- Gourraud, P-A;
- Gentil, C;
- Danjoux, M;
- Do, C;
- Negre, V;
- Bieth, A;
- Guimbaud, R;
- Trouche, D;
- Pasero, P;
- Méchali, M;
- Hoffmann, J-S;
- Cazaux, C
Publication type:
Correction Notice
A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer.
Published in:
Oncogene, 2010, v. 29, n. 6, p. 876, doi. 10.1038/onc.2009.378
By:
- Pillaire, M.-J.;
- Selves, J.;
- Gordien, K.;
- Gouraud, P.-A.;
- Gentil, C.;
- Danjoux, M.;
- Do, C.;
- Negre, V.;
- Bieth, A.;
- Guimbaud, R.;
- Trouche, D.;
- Pasero, P.;
- Méchali, M.;
- Hoffmann, J.-S.;
- Cazaux, C.
Publication type:
Article
Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase κ in colorectal cancer.
Published in:
Oncogene, 2007, v. 26, n. 23, p. 3387, doi. 10.1038/sj.onc.1210116
By:
- Lemée, F.;
- Bavoux, C.;
- Pillaire, M. J.;
- Bieth, A.;
- Machado, C. R.;
- Pena, S. D.;
- Guimbaud, R.;
- Selves, J.;
- Hoffmann, J. S.;
- Cazaux, C.
Publication type:
Article
Efficacy of Everolimus in Patients with Metastatic Insulinomas and Refractory Hypoglycemia: For the French Group of Endocrine Tumors (GTE-Renaten).
Published in:
Neuroendocrinology, 2012, v. 96, p. 20
By:
- Bernard, V.;
- Lombard-Bohas, C.;
- Goichot, B.;
- Rohmer, V.;
- Guimbaud, R.;
- Niccoli, P.;
- Chougnet, C.;
- Ruszniewski, P.;
- Baudin, E.
Publication type:
Article
Récidives pelviennes de cancers du rectum à composante extraluminale.
Published in:
Oncologie (Tech Science Press), 2015, v. 17, n. 7/8, p. 309, doi. 10.1007/s10269-015-2533-4
By:
- Pereira, P.;
- Ghouti, L.;
- Humeau, M.;
- Filleron, T.;
- Selves, J.;
- Guimbaud, R.;
- Carrere, N.;
- Portier, G.
Publication type:
Article
Cancer de l'estomac métastatique : traitement médical.
Published in:
Oncologie (Tech Science Press), 2013, v. 15, n. 3/4, p. 161, doi. 10.1007/s10269-013-2268-8
By:
- Castellano, J.;
- Guimbaud, R.
Publication type:
Article
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer.
Published in:
PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0243997
By:
- Mineur, L.;
- François, E.;
- Plassot, C.;
- Phelip, J. M.;
- Miglianico, L.;
- Dourthe, L. M.;
- Bonichon, N.;
- Moreau, L.;
- Guimbaud, R.;
- Smith, D.;
- Achille, E.;
- Hervé, R.;
- Bons, J. M.;
- Remy, S.;
- Faroux, R.;
- Villing, A. L.;
- Mahamat, A.;
- Rabbia, I.;
- Soulié, P.;
- Baumgaertner, I.
Publication type:
Article
Oncological outcome of ultra-low coloanal anastomosis with and without intersphincteric resection for low rectal adenocarcinoma.
Published in:
British Journal of Surgery, 2007, v. 94, n. 3, p. 341, doi. 10.1002/bjs.5621
By:
- Portier, G.;
- Ghouti, L.;
- Kirzin, S.;
- Guimbaud, R.;
- Rives, M.;
- Lazorthes, F.
Publication type:
Article
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Published in:
Breast Cancer Research & Treatment, 2013, v. 141, n. 1, p. 135, doi. 10.1007/s10549-013-2669-9
By:
- Pujol, P.;
- Lyonnet, D.;
- Frebourg, T.;
- Blin, J.;
- Picot, M.;
- Lasset, C.;
- Dugast, C.;
- Berthet, P.;
- Paillerets, B.;
- Sobol, H.;
- Grandjouan, S.;
- Soubrier, F.;
- Buecher, B.;
- Guimbaud, R.;
- Lidereau, R.;
- Jonveaux, P.;
- Houdayer, C.;
- Giraud, S.;
- Olschwang, S.;
- Nogue, E.
Publication type:
Article
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.
Published in:
Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1395, doi. 10.1007/s00520-012-1451-6
By:
- Reguiai, Z.;
- Bachet, J.;
- Bachmeyer, C.;
- Peuvrel, L.;
- Beylot-Barry, M.;
- Bezier, M.;
- Boucher, E.;
- Chevelle, C.;
- Colin, P.;
- Guimbaud, R.;
- Mineur, L.;
- Richard, M.;
- Artru, P.;
- Dufour, P.;
- Gornet, J.;
- Samalin, E.;
- Bensadoun, R.;
- Ychou, M.;
- André, T.;
- Dreno, B.
Publication type:
Article
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases.
Published in:
2008
By:
- Ychou, M.;
- Viret, F.;
- Kramar, A.;
- Desseigne, F.;
- Mitry, E.;
- Guimbaud, R.;
- Delpero, J. R.;
- Rivoire, M.;
- Quénet, F.;
- Portier, G.;
- Nordlinger, B.;
- Quénet, F
Publication type:
journal article
Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma.
Published in:
Familial Cancer, 2019, v. 18, n. 2, p. 173, doi. 10.1007/s10689-018-0102-6
By:
- Vande Perre, P.;
- Siegfried, A.;
- Corsini, C.;
- Bonnet, D.;
- Toulas, C.;
- Hamzaoui, N.;
- Selves, J.;
- Chipoulet, E.;
- Hoffmann, J. S.;
- Uro-Coste, E.;
- Guimbaud, R.
Publication type:
Article
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.
Published in:
Gastric Cancer, 2019, v. 22, n. 3, p. 577, doi. 10.1007/s10120-018-0885-z
By:
- Touchefeu, Y.;
- Guimbaud, R.;
- Louvet, C.;
- Dahan, L.;
- Samalin, E.;
- Barbier, E.;
- Le Malicot, K.;
- Cohen, R.;
- Gornet, J. M.;
- Aparicio, T.;
- Nguyen, S.;
- Azzedine, A.;
- Etienne, P. L.;
- Phelip, J. M.;
- Hammel, P.;
- Chapelle, N.;
- Sefrioui, D.;
- Mineur, L.;
- Lepage, C.;
- Bouche, O.
Publication type:
Article
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours.
Published in:
2005
By:
- Delord, J. P.;
- Pierga, J. Y.;
- Dieras, V.;
- Bertheault-Cvitkovic, F.;
- Turpin, F. L.;
- Lokiec, F.;
- Lochon, I.;
- Chatelut, E.;
- Canal, P.;
- Guimbaud, R.;
- Mery-Mignard, D.;
- Cornen, X.;
- Mouri, Z.;
- Bugat, R.
Publication type:
journal article
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis.
Published in:
Medical Oncology, 2011, v. 28, p. 253, doi. 10.1007/s12032-010-9716-8
By:
- Bouchahda, M.;
- Macarulla, T.;
- LIedo, G.;
- Lévi, F.;
- Elez, M.;
- Paule, B.;
- Karaboué, A.;
- Artru, P.;
- Tabernero, J.;
- Machover, D.;
- Innominato, P.;
- Goldschmidt, E.;
- Bonnet, D.;
- Ducreux, M.;
- Castagne, V.;
- Guimbaud, R.
Publication type:
Article

Found: 15